indubot

What indubot does

Indubot is a privately held Dominican Republic pharmaceutical distributor, founded in 2018 and headquartered in Santo Domingo, that imports, stores, distributes, and sells authorized medications and medical products with a focus on oncology therapies and wellness products. The company functions as a bridge between international first-tier laboratories and Dominican patients, operating through a network of physicians, healthcare institutions, and ARS (Administradoras de Riesgos de Salud / health insurance administrators).

The company's core technology is a proprietary ERP ecosystem developed by Covidia Health, which connects Indubot, physicians, patients, and health allies through interactive dashboards accessible from iOS, Android, and web. The platform provides real-time traceability of each order, batch, dispatch, and delivery; integrates pharmacovigilance monitoring across the treatment lifecycle; supports ARS authorization workflows; and coordinates monthly treatment continuity. Additional offerings include a continuous medical education program for healthcare professionals. Compliance posture includes updated Good Distribution Practices (BPA), ALCOA+ data integrity principles, digital auditing, and automated system validation.

Revenue is generated through pharmaceutical distribution transaction fees on imported medications and health products. The go-to-market combines enterprise field sales to healthcare institutions and prescribing physicians with direct-to-patient medication delivery following physician prescriptions and ARS authorization. Indubot serves a horizontal customer base across the Dominican Republic, including patients requiring oncology and wellness therapies, prescribing physicians, and healthcare institutions. The company is founder-led by CEO Dominique Tatis, with no disclosed parent company, institutional investors, or external funding rounds.

Name

indubot

Legal name

Indubot

Website

https://indubot.do

Company type

Private

Founded year

2018

Operating status

Operating

Short description

Indubot is a Dominican Republic pharmaceutical distributor, founded in 2018, that imports and distributes oncology therapies and wellness products through a proprietary ERP traceability platform connecting physicians, patients, and international laboratories with real-time pharmacovigilance and ARS authorization support.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

Keywords

• Pharmaceutical distribution
• Oncology therapies
• Pharmacovigilance platform
• Medical traceability
• Therapeutic portfolio

Headquarters

HQ city

Santo Domingo

HQ country

Dominican Republic

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Distribution: Import, storage, distribution and sale of authorized medications and medical products. The company integrates international laboratories of first level and guarantees patients benefit from therapies in their portfolio in Dominican Republic.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Indubot is a certified pharmaceutical distributor that imports, stores, distributes, and sells authorized medications and medical products in the Dominican Republic, connecting international laboratories with Dominican patients. Its core offering is built on a proprietary ERP traceability ecosystem developed by Covidia Health, which links the company, physicians, patients, and health allies through real-time interactive dashboards accessible via iOS, Android, and web. The platform enables pharmacovigilance monitoring, ARS insurance authorization tracking, monthly treatment continuity coordination, and end-to-end traceability of each order, batch, dispatch, and delivery.

Product overview

Indubot is a certified pharmaceutical distribution company operating as a unified ecosystem that combines a proprietary ERP traceability platform with pharmaceutical distribution services. The core offering consists of the Indubot Ecosystem ERP (developed by Covidia Health), which connects doctors, patients, and health allies through interactive panels accessible on iOS, Android, and web. This platform integrates with the Portafolio Terapéutico of medications and health products authorized for import and distribution, supported by a pharmacovigilance service that monitors processes from import through patient delivery. Additional services include continuous medical education for healthcare professionals. The ecosystem prioritizes patient access, treatment continuity, and scientific backing for therapies delivered in Dominican Republic.

Differentiator

Problem solved

Functional benefit

Products and services

• Indubot Ecosystem ERP Proprietary traceability platform, developed by Covidia Health, that connects Indubot, doctors, patients, and health allies through interactive dashboards accessible from iOS, Android, and web, enabling real-time monitoring of treatment processes from patient consultation through medication delivery and supporting pharmacovigilance.
• Portafolio Terapéutico (Therapeutic Portfolio) Therapeutic portfolio of medications and health products authorized for import, storage, distribution, and sale in the Dominican Republic, including oncological therapies and wellness products, expanding continuously in line with scientific advances to strengthen physician work and improve patient care.
• Farmacovigilancia Platform Integrated pharmacovigilance service that monitors critical processes from medication import through patient delivery and follow-up. The platform protects data integrity and maintains traceable evidence of each order, batch, dispatch, and delivery, enabling simultaneous monitoring by physicians and patients.
• Continuous Medical Education Ongoing medical education program for healthcare professionals that supports continuous training, updating, and strengthening of physician skills to deliver better outcomes in professional practice and greater impact on patient improvement.

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Covidia HealthcoreTechnology or IntegrationCovidia Health developed Indubot's proprietary ERP ecosystem for pharmaceutical traceability. This custom platform connects Indubot, physicians, patients, and health allies in real-time, enabling monitoring of treatment processes, pharmacovigilance, and treatment continuity coordination.
• International LaboratoriescoreStrategic or Co-development PartnerIndubot integrates international laboratories of first level, bringing their therapeutic portfolio to patients in Dominican Republic. These partnerships enable access to oncology therapies and wellness products not otherwise available in the local market.
• ARS (Health Insurance Administrators)coreChannel Partner/ Reseller/ DistributorIndubot works with ARS (Administradoras de Riesgos de Salud) for patient treatment authorization processes, enabling patients to receive medications through their health insurance coverage.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• McKesson: Global pharmaceutical distribution leader with extensive specialty and oncology distribution capabilities. Indubot operates a narrower version of the same distribution model in DR, leveraging ARS insurance authorization and pharmacovigilance workflows analogous to McKesson's specialty distribution divisions.
• Cencora (formerly AmerisourceBergen): Major pharmaceutical distributor with strong specialty biopharma services through its PharmaLex/MPLN divisions. Indubot's specialty oncology focus and ERP-enabled traceability mirror Cencora's specialty and biologics distribution services that combine compliance, insurance authorization, and traceable delivery.
• Cardinal Health: Large pharmaceutical and medical product distributor with at-Home Solutions and specialty distribution capabilities. Comparable to Indubot in combining wholesale drug distribution, traceability, and direct delivery to patients through care-provider networks.
• Biologics by McKesson: Specialty oncology and biopharmaceutical distributor within the McKesson network. Directly comparable to Indubot's oncology-focused portfolio of international laboratory therapies served through a specialty distribution and care-coordination model.
• CuraScript SD: Specialty pharmaceutical distributor focused on limited distribution drugs for complex conditions. Shares Indubot's high-touch specialty distribution model serving patients with chronic and oncology treatments through payer-coordinated workflows.
• Optum Specialty Pharmacy (formerly Diplomat Pharmacy): Specialty pharmacy distributor within UnitedHealth Group, focused on high-cost oncology and complex-condition therapies. Comparable to Indubot in managing insurance authorization, adherence, and traceability for specialty therapies across patient populations.

Broad incumbents

• Walgreens Boots Alliance: Diversified pharmacy and wholesale drug distribution company. Although primarily retail-pharmacy oriented, Walgreens Boots Alliance's pharmaceutical wholesale arm overlaps with Indubot's distribution of branded international therapies and adherence-driven delivery.
• CVS Health: Integrated pharmacy benefits manager, pharmacy retailer, and insurer (Aetna/Caremark). Indubot's ARS authorization and patient access coordination is a narrower version of CVS Health's PBM-to-patient drug delivery flow.
• PHOENIX Group: European pharmaceutical distribution leader operating across multiple countries with integrated pharmacy and IT platforms. Comparable to Indubot in operating across an integrated pharma supply chain with pharmacy and patient-facing technology overlay.

Regional players

• Droguería Suéd: Dominican Republic pharmaceutical distributor with deep local market knowledge and ARS-network relationships. Indubot's most direct domestic competitor, since both operate as certified wholesalers distributing branded international therapies within the same ARS insurance and physician network architecture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/indubot
• Instagraminstagram.com/indubot.do

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about indubot